These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5217732)

  • 21. [Research on the immunizing and antigenic properties of some viral fractions extracted from influenza viruses of type A2].
    Moisa I; Lupu R; Blaer E
    Stud Cercet Virusol; 1972; 23(2):135-40. PubMed ID: 4646493
    [No Abstract]   [Full Text] [Related]  

  • 22. Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants.
    Phan HT; Ho TT; Chu HH; Vu TH; Gresch U; Conrad U
    Vet Res; 2017 Sep; 48(1):53. PubMed ID: 28931425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Type A influenza in hens: Serological survey by hemagglutination and immunodiffusion tests].
    Anraku MM; Pinto AA; de Godoy CV; Hipólito O
    Rev Inst Med Trop Sao Paulo; 1976; 18(1):6-9. PubMed ID: 819982
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibodies against para-influenza-3-virus in agricultural domestic animals in Syria].
    Lange W
    Berl Munch Tierarztl Wochenschr; 1967 Apr; 80(8):144-6. PubMed ID: 4299021
    [No Abstract]   [Full Text] [Related]  

  • 25. The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
    Ward BJ; Pillet S; Charland N; Trepanier S; Couillard J; Landry N
    Hum Vaccin Immunother; 2018 Mar; 14(3):647-656. PubMed ID: 29252098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209
    [No Abstract]   [Full Text] [Related]  

  • 28. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the relationship between the indicator profile and prosthetic group of mucoproteins inhibitory for influenza virus haemagglutinin.
    GOTTSCHALK A; FEZEKAS DE ST GROTH S
    J Gen Microbiol; 1960 Jun; 22():690-7. PubMed ID: 13828541
    [No Abstract]   [Full Text] [Related]  

  • 30. AGGLUTINATION BY ANTIBODY OF ERYTHROCYTES SENSITIZED BY VIRUS HEMAGGLUTININ.
    LIM KA; PONG WS
    J Immunol; 1964 Apr; 92():638-47. PubMed ID: 14139037
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental studies on influenza A2 virus infection after peroral inoculation.
    Sidorova LA; Alekseyeva AK
    Acta Virol; 1973 Jul; 17(4):293-7. PubMed ID: 4148208
    [No Abstract]   [Full Text] [Related]  

  • 32. A serologic study of equine influenza.
    Halterman LG; McQueen JL
    J Am Vet Med Assoc; 1968 Oct; 153(8):1069-73. PubMed ID: 5693156
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detection of viral and host antigens contained in an allantoic culture of influenza virus by means of the passive hemagglutination test].
    Gorbunova AS; Sokovykh LI; Isachenko VA
    Vopr Virusol; 1966; 11(3):318-22. PubMed ID: 6003501
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The solution of problems involving special handling of samples and reagents in an automatic system.
    TAYLOR IE; MARSH MM
    Ann N Y Acad Sci; 1960 Jul; 87():775-81. PubMed ID: 13775606
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on live influenza virus vaccine. I. Attenuated influenza A2 Hong Kong virus and its biological and immunological characteristics (author's transl)].
    Izuchi T; Mizutani H
    Uirusu; 1973 Jun; 23(2):134-40. PubMed ID: 4808069
    [No Abstract]   [Full Text] [Related]  

  • 38. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
    Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
    Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.
    Beard CW; Easterday BC
    Avian Dis; 1973; 17(1):173-81. PubMed ID: 4697709
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigens (and recombinants) and immune response to avian influenza.
    Easterday BC
    Am J Vet Res; 1975 Apr; 36(4 Pt 2):503-4. PubMed ID: 1092217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.